Cytokinetics reported $884.28M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 521.55M 10.97M
Amgen AMGN:US USD 24.06B 4.74B
Arca Biopharma ABIO:US USD 54.42M 14.31M
Bayer BAYN:GR EUR 38.41B 1.14B
Biogen BIIB:US USD 9.77B 24.9M
Brainstorm Cell Therapeutics BCLI:US USD 7.5M 5.3M
Bristol Myers Squibb BMY:US USD 26.8B 3.39B
Capricor Therapeutics CAPR:US USD 47.5M 5.12M
Cytokinetics CYTK:US USD 884.28M 282.02M
Eisai 4523:JP JPY 585.38B 35.57B
Eli Lilly And LLY:US USD 17.64B 524.7M
Exelixis EXEL:US USD 1.84B 10.02M
Genocea Biosciences GNCA:US USD 24.41M 17.41M
Geron GERN:US USD 222.07M 5.3M
Halozyme Therapeutics HALO:US USD 653.2M 111.26M
Intra Cellular Therapies ITCI:US USD 759.76M 29.45M
Ligand Pharmaceuticals LGND:US USD 220.43M 23.35M
Novartis NOVN:VX USD 36.95B 1.19B
Regeneron Pharmaceuticals REGN:US USD 15.43B 101.3M